All lobbying filings

MILLER STRATEGIES, LLC

Lobbying for AMGEN, INC. · biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · $60,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 1

HR 3517
Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021

Lobbying activity 3

Medicare/Medicaid

Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021

Immigration

Issues related to visas

Health Issues

Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.